Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nataly Cruz-Rodriguez

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Haematologica|February 26, 2026
Exploiting metabolic dependencies in acute myeloid leukemia: DHODH inhibition meets lipid and cholesterol metabolismNataly Cruz-Rodriguez
Haematologica|April 16, 2026
RBM15 and ZMYND8 shape acute myeloid leukemia response to BCL2 inhibitorsNataly Cruz-Rodriguez
Blood|December 27, 2024
Novel treatment strategies for chronic myeloid leukemiaNataly Cruz-Rodriguez, Michael W Deininger
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2018
Epigenetics in Hematological MalignanciesNataly Cruz-Rodriguez, Alba L Combita, Jovanny Zabaleta
Haematologica|February 12, 2026
Intrinsic cellular resistance to BCR::ABL1 inhibitorsNataly Cruz-Rodriguez, Yulieth Torres-Llanos, Michael W Deininger
Frontiers in Molecular Biosciences|July 31, 2023
Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistanceCindy Mayerli Arévalo, Nataly Cruz-Rodriguez, Sandra Quijano, et al.
Leukemia|August 4, 2024
BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph<sup>+</sup> leukemias?Nataly Cruz-Rodriguez, Hua Tang, Benjamin Bateman, et al.
Frontiers in Immunology|December 16, 2024
ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemiaNathaly Poveda-Garavito, Carlos A Orozco Castaño, Yulieth Torres-Llanos, et al.
Frontiers in Molecular Biosciences|May 15, 2024
<i>MIR4435-2HG</i> as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALLYulieth Torres-Llanos, Jovanny Zabaleta, Nataly Cruz-Rodriguez, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2017
Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALLNataly Cruz-Rodriguez, Alba L Combita, Leonardo J Enciso, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Haematologica|February 26, 2026
Exploiting metabolic dependencies in acute myeloid leukemia: DHODH inhibition meets lipid and cholesterol metabolismNataly Cruz-Rodriguez
Haematologica|April 16, 2026
RBM15 and ZMYND8 shape acute myeloid leukemia response to BCL2 inhibitorsNataly Cruz-Rodriguez
Blood|December 27, 2024
Novel treatment strategies for chronic myeloid leukemiaNataly Cruz-Rodriguez, Michael W Deininger
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2018
Epigenetics in Hematological MalignanciesNataly Cruz-Rodriguez, Alba L Combita, Jovanny Zabaleta
Haematologica|February 12, 2026
Intrinsic cellular resistance to BCR::ABL1 inhibitorsNataly Cruz-Rodriguez, Yulieth Torres-Llanos, Michael W Deininger
Frontiers in Molecular Biosciences|July 31, 2023
Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistanceCindy Mayerli Arévalo, Nataly Cruz-Rodriguez, Sandra Quijano, et al.
Leukemia|August 4, 2024
BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph<sup>+</sup> leukemias?Nataly Cruz-Rodriguez, Hua Tang, Benjamin Bateman, et al.
Frontiers in Immunology|December 16, 2024
ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemiaNathaly Poveda-Garavito, Carlos A Orozco Castaño, Yulieth Torres-Llanos, et al.
Frontiers in Molecular Biosciences|May 15, 2024
<i>MIR4435-2HG</i> as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALLYulieth Torres-Llanos, Jovanny Zabaleta, Nataly Cruz-Rodriguez, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2017
Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALLNataly Cruz-Rodriguez, Alba L Combita, Leonardo J Enciso, et al.
Pageof 2